![Mogens Winkel Madsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mogens Winkel Madsen
Keine laufenden Positionen mehr
Karriereverlauf von Mogens Winkel Madsen
Ehemalige bekannte Positionen von Mogens Winkel Madsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LiPlasome Pharma A/S
![]() LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology LiPlasome Pharma A/S develops, produces and supplies drugs for chemotherapy treatment. It has developed a technology based on incapsulation of chemotherapy in liposomes (fatty molecules) that will only dissolve in and around cancer tissue (tumors or metastases). The firm’s technology will improve chemotherapy treatment within a wide range of cancer diseases significantly as it improves the balance between effect and side effects. LiPlasome’s first drug candicate LiplaCis which is a liposonal formulation of Cisplatin, is in clinical phase 1. The company was founded in January 2001 by Ole Gunner Mouritsen and is headquartered in Hoersholm, Denmark. | Geschäftsführer | 27.03.2014 | - |
Technik-/Wissenschafts-/F&E-Leiter | - | 27.03.2014 |
Statistik
International
Dänemark | 2 |
Operativ
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
LiPlasome Pharma A/S
![]() LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology LiPlasome Pharma A/S develops, produces and supplies drugs for chemotherapy treatment. It has developed a technology based on incapsulation of chemotherapy in liposomes (fatty molecules) that will only dissolve in and around cancer tissue (tumors or metastases). The firm’s technology will improve chemotherapy treatment within a wide range of cancer diseases significantly as it improves the balance between effect and side effects. LiPlasome’s first drug candicate LiplaCis which is a liposonal formulation of Cisplatin, is in clinical phase 1. The company was founded in January 2001 by Ole Gunner Mouritsen and is headquartered in Hoersholm, Denmark. | Health Technology |
- Börse
- Insiders
- Mogens Winkel Madsen
- Erfahrung